Zobrazeno 1 - 10
of 482
pro vyhledávání: '"J Alfred Witjes"'
Autor:
J Alfred Witjes, Alina Vrieling, Mihai G Netea, Leo A B Joosten, Katja K H Aben, Sita H Vermeulen, Joost L Boormans, Antoine G van der Heijden, Boris Novakovic, Jelmer H van Puffelen, Liesbeth van Emst, Denise Kooper, Tahlita C M Zuiverloon, Ursula T H Oldenhof, Tessel E Galesloot, Lambertus A L M Kiemeney, Egbert Oosterwijk
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background BCG is recommended as intravesical immunotherapy to reduce the risk of tumor recurrence in patients with non-muscle invasive bladder cancer (NMIBC). Currently, it is unknown whether intravesical BCG application induces trained immunity.Met
Externí odkaz:
https://doaj.org/article/f160d417e5fc4088a9372dbbdff54fa8
Autor:
Anne J Grotenhuis, Aleksandra M Dudek, Gerald W Verhaegh, J Alfred Witjes, Katja K Aben, Saskia L van der Marel, Sita H Vermeulen, Lambertus A Kiemeney
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89164 (2014)
In the last few years, susceptibility loci have been identified for urinary bladder cancer (UBC) through candidate-gene and genome-wide association studies. Prognostic relevance of most of these loci is yet unknown. In this study, we used data of the
Externí odkaz:
https://doaj.org/article/ed9e22312aed4b26910fb7d7392251ac
Autor:
Carl J. Wijburg, Gerjon Hannink, Charlotte T.J. Michels, Philip C. Weijerman, Rami Issa, Andrea Tay, Karel Decaestecker, Peter Wiklund, Abolfazl Hosseini, Ashwin Sridhar, John Kelly, Frederiek d'Hondt, Alexandre Mottrie, Sjoerd Klaver, Sebastian Edeling, Paolo Dell'Oglio, Francesco Montorsi, Maroeska M. Rovers, J. Alfred Witjes
Publikováno v:
European Urology Open Science, Vol 39, Iss , Pp 55-61 (2022)
Background: The utilisation of robot-assisted radical cystectomy with intracorporeal reconstruction (iRARC) has increased in recent years. Little is known about the length of the learning curve (LC) for this procedure. Objective: To study the length
Externí odkaz:
https://doaj.org/article/ce2cbb766ee5494aa167d9e95071f423
Autor:
Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Michel de Groot, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background In recent years, there is increasing evidence showing a beneficial outcome (e.g. progression free survival; PFS) after metastases-directed therapy (MDT) with external beam radiotherapy (EBRT) or targeted surgery for oligometastati
Externí odkaz:
https://doaj.org/article/05ea3477df904c7e9eba15f0eafa2c79
Autor:
Désirée van Deukeren, Berdine L. Heesterman, Lianne Roelofs, Lambertus A. Kiemeney, J. Alfred Witjes, Tineke J. Smilde, Geert J.L.H.van Leenders, Luca Incrocci, Ben G.L. Vanneste, Richard P. Meijer, Sabine Siesling, Bart P.J.van Bezooijen, Katja K.H. Aben
Publikováno v:
Cancer Treatment and Research Communications, Vol 31, Iss , Pp 100553- (2022)
Introduction: The COVID-19 outbreak has affected care for non-COVID diseases like cancer. We evaluated the impact of the COVID-19 outbreak on prostate cancer care in the Netherlands. Methods: Prostate cancer diagnoses per month in 2020–2021 versus
Externí odkaz:
https://doaj.org/article/62e35b6bbe844139ae1f744b9306941a
Autor:
Charlotte T. J. Michels, Carl J. Wijburg, Inger L. Abma, J. Alfred Witjes, Janneke P. C. Grutters, Maroeska M. Rovers
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-17 (2019)
Abstract Background The Bladder Cancer Index (BCI) and Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-Bl-Cys) were developed to measure disease-specific health-related quality of life (HRQOL) in bladder cancer patients and patients
Externí odkaz:
https://doaj.org/article/52e3bd311e534cefbccd6deb5df8b27e
Autor:
Nikoletta Vidra, Ivy Beeren, Moniek van Zutphen, Katja K. Aben, Ellen Kampman, J. Alfred Witjes, Antoine G. van der Heijden, Lambertus A. Kiemeney, Alina Vrieling
Publikováno v:
International Journal of Cancer, 152(10), 2032-2042
International Journal of Cancer, 152, 2032-2042
International Journal of Cancer 152 (2023) 10
International Journal of Cancer, 152, 10, pp. 2032-2042
International Journal of Cancer, 152, 2032-2042
International Journal of Cancer 152 (2023) 10
International Journal of Cancer, 152, 10, pp. 2032-2042
Contains fulltext : 291115.pdf (Publisher’s version ) (Open Access) Although the role of lifestyle in health-related quality of life (HRQoL) outcomes has been increasingly recognized for various types of cancer, evidence in patients with non-muscle
Autor:
Moniek van Zutphen, Jasper P. Hof, Katja KH. Aben, Ellen Kampman, J Alfred Witjes, Lambertus ALM. Kiemeney, Alina Vrieling
Publikováno v:
American Journal of Clinical Nutrition 117 (2023) 4
The American Journal of Clinical Nutrition, 117, 4, pp. 681-690
American Journal of Clinical Nutrition, 117(4), 681-690
The American Journal of Clinical Nutrition, 117, 681-690
The American Journal of Clinical Nutrition, 117, 4, pp. 681-690
American Journal of Clinical Nutrition, 117(4), 681-690
The American Journal of Clinical Nutrition, 117, 681-690
Contains fulltext : 291760.pdf (Publisher’s version ) (Open Access) BACKGROUND: Patients with non-muscle invasive bladder cancer (NMIBC) are at a high risk of tumor recurrence. It has not been previously investigated if adherence to cancer preventi
Autor:
Morgan Rouprêt, Paolo Gontero, Stuart R.C. McCracken, Tim Dudderidge, Jacqueline Stockley, Ashleigh Kennedy, Oscar Rodriguez, Caroline Sieverink, Felicien Vanié, Marco Allasia, J. Alfred Witjes, Marc Colombel, Fabrizio Longo, Emanuele Montanari, Joan Palou, Richard J. Sylvester
Publikováno v:
European Urology Focus, 8, 1643-1649
European Urology Focus, 8, 6, pp. 1643-1649
European Urology Focus, 8, 6, pp. 1643-1649
Contains fulltext : 287583.pdf (Publisher’s version ) (Open Access) BACKGROUND: Non-muscle-invasive bladder cancer (NMIBC) is one of the most expensive cancers owing to frequent follow-up cystoscopies for detection of recurrence. OBJECTIVE: To asse
Autor:
Wei Shen Tan, Gary Steinberg, J. Alfred Witjes, Roger Li, Shahrokh F. Shariat, Morgan Roupret, Marko Babjuk, Trinity J. Bivalacqua, Sarah P. Psutka, Stephen B. Williams, Michael S. Cookson, Juan Palou, Ashish M. Kamat
Publikováno v:
European Urology Oncology, 5, 5, pp. 505-516
European Urology Oncology, 5, 505-516
European Urology Oncology, 5, 505-516
Item does not contain fulltext CONTEXT: Intermediate-risk (IR) non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease. OBJECTIVE: To update the International Bladder Cancer Group (IBCG) guidance and provide practical recommendations on